Ambu A/S narrowed earnings guidance for the full-year 2022/23. For the year, the company expected organic revenue growth guidance to 6%-8%, previously 5%-8%; EBIT margin before special items: 5-6% (maintained as per 10 July 2023).
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
128.6 DKK | -0.08% | -2.05% | +22.58% |
15/05 | Nordic Shares Moved Upward Wednesday; BioArctic Series B Topped Leaders | DJ |
14/05 | Transcript : Ambu A/S, Q2 2024 Earnings Call, May 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.58% | 497.93Cr | |
-4.77% | 18TCr | |
+4.10% | 11TCr | |
-3.85% | 6.78TCr | |
+5.19% | 5.19TCr | |
+5.54% | 4.32TCr | |
+6.07% | 4.11TCr | |
+23.81% | 3.21TCr | |
+15.86% | 2.5TCr | |
-5.06% | 2.44TCr |
- Stock Market
- Equities
- AMBU B Stock
- News Ambu A/S
- Ambu A/S Narrows Earnings Guidance for the Full-Year 2022/23